News
BASSE-TERRE, France A French woman from the Caribbean island of Guadeloupe has been identified as the only known carrier of a ...
An engineered protein turns off the kind of immune cells most likely to damage tissue as part of type-1 diabetes, hepatitis, ...
Explore the rapidly growing Global Vectorized Antibodies Market, projected to soar from USD 9.49 billion in 2025 to USD 15.94 ...
12h
Zacks Investment Research on MSNBio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its StockBio-Techne Corp. TECH has recently entered into a distribution agreement with the U.S. Pharmacopeia (“USP”) to sell USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) reference ...
Pfizer's hemophilia therapy, Hympavzi, met the main goal of a late-stage study in patients with certain types of antibodies, ...
This valuable study identifies asymmetric dimethylarginine (ADMA) histones as potential determinants of the initial genomic binding of Rhino, a Drosophila-specific chromatin protein essential for ...
Bio-Techne Corporation (NASDAQ:TECH) is one of the best S&P 500 stocks with huge upside potential. On June 24, Bio-Techne ...
Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...
Our immune systems don't always react in the right way, but scientists are learning more about why that happens... | Genetics And Genomics ...
Bio-Techne (NASDAQ:TECH) signed a distribution agreement with the U.S. Pharmacopeia (USP) that allows the company to offer USP monoclonal antibody (mAb) and recombinant adeno-associated virus (AAV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results